More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.23B
EPS
-0.02
P/E ratio
--
Price to sales
6.86
Dividend yield
--
Beta
0.902679
Previous close
$3.38
Today's open
$3.38
Day's range
$3.32 - $3.38
52 week range
$2.28 - $3.61
show more
CEO
Michael Gorenstein
Employees
356
Headquarters
Stayner, Ontario
Exchange
NASDAQ Global Market
Shares outstanding
368412864
Issue type
Common Stock
Healthcare
Pharmaceuticals
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Here is how Cronos Group (CRON) and Amgen (AMGN) have performed compared to their sector so far this year.
Zacks Investment Research • Oct 26, 2026

Cronos (CRON) Upgraded to Strong Buy: Here's What You Should Know
Cronos (CRON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Investment Research • Oct 23, 2026

Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027
GlobeNewsWire • Oct 15, 2026

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1.
GlobeNewsWire • Oct 13, 2026

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.
Zacks Investment Research • Oct 9, 2026

Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
GlobeNewsWire • Oct 8, 2026

Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript
Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript
Seeking Alpha • Sep 25, 2026

Cronos Hosts 2026 Investor Day
TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location.
GlobeNewsWire • Sep 24, 2026

Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
Cronos Group NASDAQ: CRON used its first Investor Day to outline its cultivation, genetics, brand and financial strategy, emphasizing its purpose-built greenhouse partnership with Mucci Farms, continued international expansion and a focus on cash flow generation.
MarketBeat • Sep 24, 2026

Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 Registration is now open for Cronos' first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026
GlobeNewsWire • Sep 15, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Cronos Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.